The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

MLA

Marrie, Ruth Ann, et al. “The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Multiple Sclerosis.” Multiple Sclerosis & Related Disorders, vol. 20, Feb. 2018, pp. 9–15. EBSCOhost, https://doi.org/10.1016/j.msard.2017.12.007.

APA

Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Bolton, J. M., Sareen, J., El-Gabalawy, R., Marriott, J. J., & Bernstein, C. N. (2018). The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple Sclerosis & Related Disorders, 20, 9–15. https://doi.org/10.1016/j.msard.2017.12.007

Chicago

Marrie, Ruth Ann, Lixia Zhang, Lisa M. Lix, Lesley A. Graff, John R. Walker, John D. Fisk, Scott B. Patten, et al. 2018. “The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Multiple Sclerosis.” Multiple Sclerosis & Related Disorders 20 (February): 9–15. doi:10.1016/j.msard.2017.12.007.